Credit Suisse
CTSO icon

Credit Suisse’s Cytosorbents Corp CTSO Stock Holding History

Credit Suisse’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed – – 4079
2022
Q2 		$0 Buy
+1
New +$46 ﹤0.01% 3995
2021
Q1 		– Sell
-590
Closed -$94K – 4336
2020
Q4 		$94K Buy
+590
New +$98.8K ﹤0.01% 4188
2019
Q4 		– Sell
-531
Closed -$53K – 4182
2019
Q3 		$53K Sell
531
-257
-33% -$29.9K ﹤0.01% 4028
2019
Q2 		$104K Buy
+788
New +$108K ﹤0.01% 3945
2018
Q2 		– Sell
-693
Closed -$98K – 3997
2018
Q1 		$98K Sell
693
-514
-43% -$77.7K ﹤0.01% 3799
2017
Q4 		$157K Buy
+1,207
New +$154K ﹤0.01% 3787
2016
Q2 		– Sell
-1,276
Closed -$100K – 4219
2016
Q1 		$100K Buy
1,276
+548
+75% +$47.6K ﹤0.01% 3826
2015
Q4 		$81K Buy
+728
New +$99.1K ﹤0.01% 4090

Other funds holding CTSO

Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
Avenir Corporation
Avenir Corporation Alexandria, Virginia $812M AUM 0.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $867M AUM 20.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Redmile Group
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Credit Suisse's CTSO Position: Q3 2022 in Review

Credit Suisse sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 1 share.

Credit Suisse first reported a position in CTSO in Q4 2015 and held it in 8 quarters. The position peaked at $157K in Q4 2017. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Credit Suisse reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 1 Cytosorbents Corp share in Q3 2022.
  • Credit Suisse first reported a position in Cytosorbents Corp in Q4 2015 and held it in 8 quarters.
  • Credit Suisse's Cytosorbents Corp position peaked at $157K in Q4 2017.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.